Ezetimibe e Atorvastatina DOC

Ezetimibe and Atorvastatina DOC is a generic prescription medication used for the treatment of high cholesterol. It is marketed by DOC Generici, an Italian pharmaceutical leader known for providing affordable generic alternatives to name-brand medicines. While DOC Generici is based in Italy, generic medications like these are often manufactured through a complex global supply chain of active ingredient suppliers and packaging plants located in various countries within the European Union and internationally.

The history of the brand is tied to the evolution of the Italian generic market. DOC Generici was founded in 1996 and quickly became a pillar of the healthcare system in Italy. Over the years, the ownership of the company has shifted between several private equity firms, including CVC Capital Partners and Charterhouse Capital Partners. Currently, it is part of a larger global healthcare investment portfolio, maintaining its strong local identity while benefiting from international financial backing.